These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 30292735)

  • 41. Linking Smoking, Coffee, Urate, and Parkinson's Disease - A Role for Gut Microbiota?
    Scheperjans F; Pekkonen E; Kaakkola S; Auvinen P
    J Parkinsons Dis; 2015; 5(2):255-62. PubMed ID: 25882059
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Environmental triggers of Parkinson's disease - Implications of the Braak and dual-hit hypotheses.
    Chen H; Wang K; Scheperjans F; Killinger B
    Neurobiol Dis; 2022 Feb; 163():105601. PubMed ID: 34954321
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Unhealthy gut, unhealthy brain: The role of the intestinal microbiota in neurodegenerative diseases.
    Spielman LJ; Gibson DL; Klegeris A
    Neurochem Int; 2018 Nov; 120():149-163. PubMed ID: 30114473
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Faecal metabolite deficit, gut inflammation and diet in Parkinson's disease: Integrative analysis indicates inflammatory response syndrome.
    Augustin A; Guennec AL; Umamahesan C; Kendler-Rhodes A; Tucker RM; Chekmeneva E; Takis P; Lewis M; Balasubramanian K; DeSouza N; Mullish BH; Taylor D; Ryan S; Whelan K; Ma Y; Ibrahim MAA; Bjarnason I; Hayee BH; Charlett A; Dobbs SM; Dobbs RJ; Weller C
    Clin Transl Med; 2023 Jan; 13(1):e1152. PubMed ID: 36588088
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Explore the Effects of Fe₃O₄ Nanoparticles and Oxidative Stress and Neuroinflammatory Responses on the Intestinal Flora Based on a Parkinson Rat Model.
    Xu L; Mayila T; Wang J
    J Nanosci Nanotechnol; 2021 Feb; 21(2):1176-1183. PubMed ID: 33183459
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Probiotics for Parkinson's Disease.
    Gazerani P
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450864
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gut microbiota in patients with Parkinson's disease in southern China.
    Lin A; Zheng W; He Y; Tang W; Wei X; He R; Huang W; Su Y; Huang Y; Zhou H; Xie H
    Parkinsonism Relat Disord; 2018 Aug; 53():82-88. PubMed ID: 29776865
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease.
    Imhann F; Vich Vila A; Bonder MJ; Fu J; Gevers D; Visschedijk MC; Spekhorst LM; Alberts R; Franke L; van Dullemen HM; Ter Steege RWF; Huttenhower C; Dijkstra G; Xavier RJ; Festen EAM; Wijmenga C; Zhernakova A; Weersma RK
    Gut; 2018 Jan; 67(1):108-119. PubMed ID: 27802154
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gut microbiota, 1013 new pieces in the Parkinson's disease puzzle.
    Scheperjans F
    Curr Opin Neurol; 2016 Dec; 29(6):773-780. PubMed ID: 27653288
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Oral microbiota and inflammatory bowel disease].
    Zhang HN; Zhou XD; Xu X; Wang Y
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2019 Aug; 37(4):443-449. PubMed ID: 31512842
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Review: The Role of Intestinal Dysbiosis in Parkinson's Disease.
    Huang Y; Liao J; Liu X; Zhong Y; Cai X; Long L
    Front Cell Infect Microbiol; 2021; 11():615075. PubMed ID: 33968794
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Gut Microbiota in Inflammatory Bowel Disease.
    Sheehan D; Shanahan F
    Gastroenterol Clin North Am; 2017 Mar; 46(1):143-154. PubMed ID: 28164847
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cellular and molecular mechanisms underlying NOD2 risk-associated polymorphisms in Crohn's disease.
    Strober W; Asano N; Fuss I; Kitani A; Watanabe T
    Immunol Rev; 2014 Jul; 260(1):249-60. PubMed ID: 24942694
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Changes of Colonic Bacterial Composition in Parkinson's Disease and Other Neurodegenerative Diseases.
    Gerhardt S; Mohajeri MH
    Nutrients; 2018 Jun; 10(6):. PubMed ID: 29857583
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The role of the gut microbiome in idiopathic Parkinson's disease].
    Unger MM; Becker A; Keller A; Schäfer KH; Schwiertz A; Oertel WH
    Nervenarzt; 2020 Dec; 91(12):1085-1095. PubMed ID: 33025073
    [TBL] [Abstract][Full Text] [Related]  

  • 56. More than constipation - bowel symptoms in Parkinson's disease and their connection to gut microbiota.
    Mertsalmi TH; Aho VTE; Pereira PAB; Paulin L; Pekkonen E; Auvinen P; Scheperjans F
    Eur J Neurol; 2017 Nov; 24(11):1375-1383. PubMed ID: 28891262
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [A role of the gastrointestinal tract microbiota in the pathogenesis of Parkinson's disease].
    Alifirova VM; Zhukova NG; Zhukova IA; Latypova AV; Titova MA; Mironova YS; Izhboldina OP; Nikitina MA; Petrov VA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11):174-179. PubMed ID: 28635757
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The gut microbiota and inflammatory bowel diseases.
    Miyoshi J; Chang EB
    Transl Res; 2017 Jan; 179():38-48. PubMed ID: 27371886
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structural changes of gut microbiota in Parkinson's disease and its correlation with clinical features.
    Li W; Wu X; Hu X; Wang T; Liang S; Duan Y; Jin F; Qin B
    Sci China Life Sci; 2017 Nov; 60(11):1223-1233. PubMed ID: 28536926
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gut microbiota are related to Parkinson's disease and clinical phenotype.
    Scheperjans F; Aho V; Pereira PA; Koskinen K; Paulin L; Pekkonen E; Haapaniemi E; Kaakkola S; Eerola-Rautio J; Pohja M; Kinnunen E; Murros K; Auvinen P
    Mov Disord; 2015 Mar; 30(3):350-8. PubMed ID: 25476529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.